An observational study in Coronary Artery Disease, sponsored by Tomas Bata Hospital, Czech Republic. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-01-06.
Sponsored by Tomas Bata Hospital, Czech Republic · Observational
A prospective study aiming to analyse the relation between different variables and high sensitivity troponin I (hsTnI) elevation within a group of patients undergoing a coronary angiography with or without subsequent percutaneous coronary intervention.
The study tries to seek potential causes and context of subclinical myocardial injury within patients with baseline concentration of hsTnI below the 99th percentile value upper reference limit or with demonstrated fall of hsTnI levels.
5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.
This study's enrollment of 220 is below the median of 336 across 1,947 observational studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →Tomas Bata Hospital, Czech Republic is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive patients referred for coronary angiography (CAG): stable patients with presumed coronary artery disease, or those referred for acute coronary syndrome without ST-segment elevation (NSTE-ACS) meeting the criteria of low risk with demostrated fall of cTn levels, or patients prepared for cardiac surgery.
Exclusion Criteria:
Diagnostic coronary angiography only
Diagnostic coronary angiography and subsequent percutaneous coronary intervention (PCI)
Subclinical myocardial injury
Time frame: up to 24 hours after procedure
Postprocedural myocardial infarction
Time frame: up to 24 hours after procedure
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tomas Bata Hospital, Czech Republic